DataVault AI (DVLT) and Wellgistics Health (WGRX) announced the two companies have entered into a non-binding letter of intent to implement manufacturer-to-patient blockchain-enabled smart contracts into Wellgistics proprietary Technology and Physical infrastructure for the prescription drug industry. The goal of the partnership will be to seek to fully digitize tracking of prescription drugs from script to fulfillment in order to ensure the right drug gets to the right patient at the right time, with the right recommendations for safe and effective use. The companies currently contemplate a revenue-sharing arrangement from fees derived from the use of the PharmacyChain by pharmacies. Wellgistics recently announced the introduction of HubRx AI, a fully customizable artificial intelligence agent engine designed to streamline the implementation of AI Agents for pharmacies. The AI Agents will help optimize prescription drug services, reduce pharmacist costs and improve patient outcomes while adhering to strict healthcare privacy, security and compliance controls.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVLT:
- Datavault AI (NASDAQ: DVLT) Appoints U.S. Navy SEAL Veteran Pete Scobell as Vice President, Global Security
- Datavault AI (NASDAQ: DVLT) Partners with Max International to Launch Swiss Digital RWA Exchange
- Datavault announces strategic partnership with Max International AG
- Datavault files to sell 5M shares of common stock for holders
- Datavault AI (NASDAQ: DVLT) Expands WiSA Portfolio with Falcon Transmitter Module, Connect App, and Certification Platform